Panolos Bioscience
PrivateLast Round
Grant
May 20, 2024
Est. Valuation
$80.44M
Total Funding Raised
$28.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Panolos Bioscience is a biopharmaceutical company that develops multi-specific therapeutics for cancer, autoimmune, and rare diseases using its proprietary αART protein design technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Panolos Bioscience Comparables
Compare Panolos Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novelty Nobility Inc. | 81% | |
| Kanaph Therapeutics | 78% | |
| ABL Bio, Inc. | 76% | |
Panolos Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 20, 2024 | ||||
| Series A | May 17, 2021 | ||||
| Pre Seed | Sep 1, 2020 | ||||
| Angel | Feb 1, 2020 |
Key People
Founding team and executive leadership
Panolos Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UTC Investment | Series A |
| JL Partners | Series A |
| Government of South Korea | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 732% MoM, reaching 1.2K.
- May 17, 2021
$18M round led by OCI Holdings.
Panolos Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Panolos Bioscience's valuation, stock price, and market status.